Key Details
Price
$12.00Annual ROE
-126.06%Beta
-0.07Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 22, 2024Recent annual earnings:
Mar 23, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
June 12, 2023Analyst ratings
Recent major analysts updates
12 May '23 HC Wainwright & Co.
Buy04 Apr '23 HC Wainwright & Co.
Buy09 Aug '22 HC Wainwright & Co.
Buy04 Apr '22 Jefferies
Buy13 Apr '21 Jefferies
Buy13 Apr '21 Evercore ISI Group
Outperform13 Apr '21 B of A Securities
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Finch Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
4 Penny Stocks To Buy According To Analysts, Targets Up To 1,650%
FNCH
PennyStocks19 April 2023
Penny stocks to buy according to analysts. The post 4 Penny Stocks To Buy According To Analysts, Targets Up To 1,650% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
FAQ
- What is the primary business of Finch Therapeutics?
- What is the ticker symbol for Finch Therapeutics?
- Does Finch Therapeutics pay dividends?
- What sector is Finch Therapeutics in?
- What industry is Finch Therapeutics in?
- What country is Finch Therapeutics based in?
- When did Finch Therapeutics go public?
- Is Finch Therapeutics in the S&P 500?
- Is Finch Therapeutics in the NASDAQ 100?
- Is Finch Therapeutics in the Dow Jones?
- When was Finch Therapeutics's last earnings report?
- When does Finch Therapeutics report earnings?
- Should I buy Finch Therapeutics stock now?
What is the primary business of Finch Therapeutics?
Finch Therapeutics is a biotechnology company focused on developing microbiome-based therapies. They aim to treat various diseases by restoring the balance of bacteria in the gut. Their innovative approach uses natural microorganisms to improve health and support the body's immune system.
What is the ticker symbol for Finch Therapeutics?
The ticker symbol for Finch Therapeutics is NASDAQ:FNCH
Does Finch Therapeutics pay dividends?
No, Finch Therapeutics does not pay dividends
What sector is Finch Therapeutics in?
Finch Therapeutics is in the Healthcare sector
What industry is Finch Therapeutics in?
Finch Therapeutics is in the Biotechnology industry
What country is Finch Therapeutics based in?
Finch Therapeutics is headquartered in United States
When did Finch Therapeutics go public?
Finch Therapeutics's initial public offering (IPO) was on 19 March 2021
Is Finch Therapeutics in the S&P 500?
No, Finch Therapeutics is not included in the S&P 500 index
Is Finch Therapeutics in the NASDAQ 100?
No, Finch Therapeutics is not included in the NASDAQ 100 index
Is Finch Therapeutics in the Dow Jones?
No, Finch Therapeutics is not included in the Dow Jones index
When was Finch Therapeutics's last earnings report?
Finch Therapeutics's most recent earnings report was on 22 November 2024
When does Finch Therapeutics report earnings?
The date for Finch Therapeutics's next earnings report has not been announced yet
Should I buy Finch Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions